Research Article
Low-Dose Ketamine Infusion for Perioperative Pain Management in Patients Undergoing Laparoscopic Gastric Bypass: A Prospective Randomized Controlled Trial
Table 2
Medical comorbidity data between the two therapy groups.
| | Medical comorbidities between groups | | | C | K | Total | value | | (N = 18) | (N = 17) | (N = 35) |
| | A-fib | | | | 0.29651 | | N | 18 (100.0%) | 16 (94.1%) | 34 (97.1%) | | | Y | 0 (0.0%) | 1 (5.9%) | 1 (2.9%) | |
| | Asthma | | | | 0.58081 | | N | 16 (88.9%) | 16 (94.1%) | 32 (91.4%) | | | Y | 2 (11.1%) | 1 (5.9%) | 3 (8.6%) | |
| | CAD | | | | 0.32411 | | N | 17 (94.4%) | 17 (100.0%) | 34 (97.1%) | | | Y | 1 (5.6%) | 0 (0.0%) | 1 (2.9%) | |
| | Chronic pain | | | | 0.51191 | | N | 17 (94.4%) | 15 (88.2%) | 32 (91.4%) | | | Y | 1 (5.6%) | 2 (11.8%) | 3 (8.6%) | |
| | COPD | | | | 0.29651 | | N | 18 (100.0%) | 16 (94.1%) | 34 (97.1%) | | | Y | 0 (0.0%) | 1 (5.9%) | 1 (2.9%) | |
| | CPAP | | | | 0.58081 | | N | 8 (44.4%) | 6 (35.3%) | 14 (40.0%) | | | Y | 10 (55.6%) | 11 (64.7%) | 21 (60.0%) | |
| | Depression | | | | 0.77381 | | N | 13 (72.2%) | 13 (76.5%) | 26 (74.3%) | | | Y | 5 (27.8%) | 4 (23.5%) | 9 (25.7%) | |
| | GERD | | | | 0.60051 | | N | 9 (50.0%) | 10 (58.8%) | 19 (54.3%) | | | Y | 9 (50.0%) | 7 (41.2%) | 16 (45.7%) | |
| | HF | | | | 0.29651 | | N | 18 (100.0%) | 16 (94.1%) | 34 (97.1%) | | | Y | 0 (0.0%) | 1 (5.9%) | 1 (2.9%) | |
| | HLD | | | | 0.35761 | | N | 10 (55.6%) | 12 (70.6%) | 22 (62.9%) | | | Y | 8 (44.4%) | 5 (29.4%) | 13 (37.1%) | |
| | HTN | | | | 0.22911 | | N | 10 (55.6%) | 6 (35.3%) | 16 (45.7%) | | | Y | 8 (44.4%) | 11 (64.7%) | 19 (54.3%) | |
| | Morbid obesity | | | | | | Y | 18 (100.0%) | 17 (100.0%) | 35 (100.0%) | |
| | OA | | | | 0.02791 | | N | 17 (94.4%) | 11 (64.7%) | 28 (80.0%) | | | Y | 1 (5.6%) | 6 (35.3%) | 7 (20.0%) | |
| | OSA | | | | 0.82591 | | N | 7 (38.9%) | 6 (35.3%) | 13 (37.1%) | | | Y | 11 (61.1%) | 11 (64.7%) | 22 (62.9%) | |
| | PONV | | | | 0.96681 | | N | 17 (94.4%) | 16 (94.1%) | 33 (94.3%) | | | Y | 1 (5.6%) | 1 (5.9%) | 2 (5.7%) | |
| | T2DM | | | | 0.05291 | | N | 15 (83.3%) | 9 (52.9%) | 24 (68.6%) | | | Y | 3 (16.7%) | 8 (47.1%) | 11 (31.4%) | |
|
|
1Chi-square test. A-fib = atrial fibrillation, CAD = coronary artery disease, COPD = chronic obstructive pulmonary disease, CPAP = continuous positive airway pressure device use, GERD = gastroesophageal reflux disease, HF = heart failure, HLD = hyperlipidemia, HTN = hypertension, OA = osteoarthritis, OSA = obstructive sleep apnea, PONV = postoperative nausea and vomiting, and T2DM = type 2 diabetes mellitus.
|
